rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PTN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Palatin Technologies, Inc. Q1 2027 Earnings Call Summary
      Nov 17Yahoo FinancePTN
      Earnings call transcript: Palatin Technologies Q1 2026 misses as stock falls 14%
      Nov 17Investing.comPTN
      Palatin’s New Rare-Obesity Candidate Shows Promise for Weekly Treatment (NASDAQ: PTN)
      Nov 17BenzingaPTN
      Palatin to Report First Quarter Fiscal Year 2027 Results

      Palatin Technologies, Inc. (Nasdaq: PTN) will announce its first quarter fiscal year 2027 operating results on Tuesday, November 17, 2026, before the open of the U.S. financial markets.

      Nov 13Yahoo FinancePTN
      AstraZeneca’s Reported $10 Billion Rhythm Bid Raises the Stakes for Palatin’s Obesity Pipeline (NASDAQ: P
      Nov 11BenzingaAZNPTN
      Palatin’s Peptide Is Advancing Toward the Clinic as Big Pharma Pays Billions for Early Peptides (NASDAQ
      Nov 9BenzingaPTN
      This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
      Nov 6BenzingaPTN
      Big Pharma’s Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)
      Oct 21Investing.comPTN
      Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)
      Oct 21BenzingaPTN
      Palatin Technologies, Inc. Q4 2026 Earnings Call Summary

      Moby summary of Palatin Technologies, Inc.'s Q4 2026 earnings call

      Sep 29Yahoo FinancePTN
      Palatin (PTN) Q4 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Sep 29The Globe and MailPTN
      Earnings call transcript: Palatin Technologies posts progress in Q4 2026, shares volatile
      Sep 28Investing.comPTN
      Palatin Targets the Next Generation of Rare Obesity Therapies After MC4R Validation (NASDAQ: PTN) - Palat

      WSW, NY, September 28th, 2026, FinanceWireThe obesity market has been transformed by GLP-1 therapies, but the next phase of innovation is increasingly expanding beyond GLP-1 alone. One small biotechnology company

      Sep 28BenzingaPTN
      Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
      Sep 28Yahoo FinancePTN

      This is the newest page. Registered accounts read further back.